24.02.2013 Views

A Guide to the Russian Academy of Sciences - University of Texas ...

A Guide to the Russian Academy of Sciences - University of Texas ...

A Guide to the Russian Academy of Sciences - University of Texas ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Golgi network and reached <strong>the</strong> cy<strong>to</strong>sol. The crystal structure <strong>of</strong> Shiga <strong>to</strong>xin, an<br />

AB5 hexamer, has been determined at 2.5 resolution. The A subunit interacts with<br />

<strong>the</strong> B pentamer via C-terminal helix and a four-stranded mixed -sheet. The fold <strong>of</strong><br />

<strong>the</strong> rest <strong>of</strong> <strong>the</strong> A subunit is similar <strong>to</strong> that <strong>of</strong> A chain <strong>of</strong> plant <strong>to</strong>xin ricin; both are Nglycosidases.<br />

However, <strong>the</strong> active site in <strong>the</strong> bacterial holo<strong>to</strong>xin is blocked by a<br />

segment <strong>of</strong> polypeptide chain. These residues <strong>of</strong> A subunit would be released as a<br />

part <strong>of</strong> <strong>the</strong> <strong>to</strong>xin activation mechanism.<br />

1997 update: CELL ENGINEERING<br />

Head Vladimir S. Prassolov, Ph.D, D.Sc.<br />

In 1995 our efforts were focused on <strong>the</strong> creation <strong>of</strong> new vec<strong>to</strong>rs with <strong>the</strong> cloned gene<br />

regulated expression in mammalian cells, including human ones. A self-inactivating<br />

retroviral vec<strong>to</strong>r containing polylinker and conveying <strong>the</strong> resistance <strong>to</strong> antibiotic<br />

G418 was constructed. Based on this construct, a retroviral vec<strong>to</strong>r has been made<br />

that contains p53-responsive element modulating <strong>the</strong> hygromycin resistance gene<br />

expression. We suppose that <strong>the</strong> introduction <strong>of</strong> this vec<strong>to</strong>r in<strong>to</strong> <strong>the</strong> cells bearing <strong>the</strong><br />

wild type p53 will provide <strong>the</strong> resistance <strong>to</strong> hygromycin, whereas <strong>the</strong> cells carrying<br />

mutant p53 will die. The development <strong>of</strong> this approach seems <strong>to</strong> be promising for<br />

gene <strong>the</strong>rapy. The analysis <strong>of</strong> p53-binding elements from p53-responsive genes has<br />

been carried out. Recombinant plasmids were constructed in which expression <strong>of</strong> a<br />

reporter gene <strong>of</strong> chloramphenicol-acetyl transferase is under control <strong>of</strong> a promoter<br />

containing p53-responsive elements. The p53-responsive elements from different<br />

genes were shown <strong>to</strong> display very different p53-dependent enhancer activity in<br />

CAT assays. The p53-responsive elements from human WAF1 and ADA genes<br />

exhibited <strong>the</strong> highest enhancer activity. This work was done in collaboration with<br />

<strong>the</strong> Labora<strong>to</strong>ry <strong>of</strong> cell proliferation. As a part <strong>of</strong> <strong>the</strong> project dealing with <strong>the</strong> study <strong>of</strong><br />

neuropathologic lesions induced by different murine leukemia viruses <strong>the</strong> cell lines<br />

were created able <strong>to</strong> produce recombinant retroviruses. These viruses were<br />

constructed on <strong>the</strong> basis <strong>of</strong> Moloney murine leukemia virus and contained a mutant<br />

LTR and an amphotropic env gene. The kinetics <strong>of</strong> <strong>the</strong> CNS lesion development is<br />

modulated by Freund leukemia virus in <strong>the</strong> case <strong>of</strong> co-infection with <strong>the</strong> abovementioned<br />

viruses. These studies are carried out in cooperation with <strong>the</strong> Department<br />

<strong>of</strong> Virus and Cell Genetics, Heinrich-Pette Institute <strong>of</strong> Experimental Virology and<br />

Immunology, <strong>University</strong> <strong>of</strong> Hamburg, Germany. In 1995 studying <strong>the</strong> mechanism<br />

<strong>of</strong> eukaryotic cell electrotransfection continued in cooperation with E. S.<br />

Tsymbalyuk, A. N. Frumkin Institute <strong>of</strong> Electrochemistry, RAS, Moscow. The<br />

method <strong>of</strong> electrotransfection <strong>of</strong> <strong>the</strong> support-anchored cells by <strong>the</strong> double-impulse<br />

electrotransfection technique was fur<strong>the</strong>r developed, and this allowed us <strong>to</strong> increase<br />

<strong>the</strong> effectivity till standard parameters <strong>of</strong> <strong>the</strong> single-impulse electrotreatment. On <strong>the</strong><br />

o<strong>the</strong>r side, <strong>the</strong> earlier described electrotransfection by <strong>the</strong> low-voltage (nonporing)<br />

impulse action on <strong>the</strong> preliminarily electroporated anchored cells was demonstrated<br />

both for COS-1, and CHO, and HeLa cells. In this case <strong>the</strong> electrotransfection level<br />

comparable with that in control (electrotransfection by <strong>the</strong> exponentially lowering<br />

impulse) allows us <strong>to</strong> state that we were <strong>the</strong> first in <strong>the</strong> world who managed <strong>to</strong><br />

separate electrotransfection process in<strong>to</strong> two steps: 1). electroporation <strong>of</strong> <strong>the</strong> cells<br />

and 2). plasmid DNA seizure in<strong>to</strong> electroporated cells caused by <strong>the</strong> low-voltage<br />

field (this step is equivalent <strong>to</strong> <strong>the</strong> low-voltage part <strong>of</strong> exponential impulse). The<br />

above results were presented at <strong>the</strong> 23d FEBS Meeting, August 13-18, Basel,<br />

Switzerland.<br />

1997 update: CELL PROLIFERATION<br />

Head Peter M. Chumakov, M.D., Ph.D., D.Sc.<br />

522

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!